Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by L & S Advisors Inc

L & S Advisors Inc lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% in the fourth quarter, HoldingsChannel reports. The firm owned 22,023 shares of the medical equipment provider’s stock after selling 404 shares during the quarter. Intuitive Surgical makes up approximately 1.3% of L & S Advisors Inc’s holdings, making the stock its 12th largest holding. L & S Advisors Inc’s holdings in Intuitive Surgical were worth $11,495,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management lifted its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC boosted its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.2 %

Shares of NASDAQ:ISRG opened at $491.84 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a market capitalization of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The business has a 50-day moving average price of $556.28 and a two-hundred day moving average price of $532.34.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Barclays boosted their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.